You are here

Daxas

Takeda’s Daxas Fails to Win U.K. Cost Agency’s Backing

Bloomberg

Wed, 01/25/12 - 09:29 am

Merck Asked by U.K. Agency for More Tests of Smoker’s Cough Drug

Bloomberg

Thu, 12/8/11 - 11:23 am

Forest Laboratories' Looming Patent Problems

Minyanville

Thu, 10/28/10 - 03:43 pm

Forest Laboratories responds to FDA Daxas request

Yahoo/AP

Mon, 09/13/10 - 08:25 pm

EU backs Nycomed's Daxas in deadly lung disease

Reuters

Tue, 07/6/10 - 11:46 am

Merck, Nycomed to jointly market COPD treatment

Marketwatch

Mon, 04/26/10 - 09:22 am

Yes+Yes=No? Forest's Daxas and the Pull of Comparative Studies

InVivo

Mon, 04/12/10 - 09:46 am

comparative effectiveness

Nycomed Still Plans IPO

WSJ Online

Mon, 04/12/10 - 09:38 am

FDA Panel Deals Blow to Forest

Yahoo/Zacks

Sat, 04/10/10 - 12:20 pm

Forest Labs Off 8% as FDA Torpedos Daxas

Barron's

Thu, 04/8/10 - 09:04 am

Suicide Risk May Not Slow Approval of Forest’s Experimental Lung Drug

WSJ Online

Mon, 04/5/10 - 07:09 pm

Drug stocks sluggish; Forest falls

Marketwatch

Mon, 04/5/10 - 11:21 am

Daxas Shows Promise

Yahoo/Zacks

Sat, 08/29/09 - 10:59 am

Nycomed Smoker’s Cough Drug Helps Lung Function, Studies Show

Bloomberg

Fri, 08/28/09 - 07:25 am

Forest Laboratories signs deal to sell Nycomed's chronic bronchitis drug Daxas in US

Yahoo/AP

Mon, 08/10/09 - 09:50 am

Nycomed submits Daxas lung drug for EU approval

Reuters

Fri, 05/8/09 - 07:08 am

Nycomed hopes for Daxas deal, targets IPO

Reuters

Tue, 05/5/09 - 09:33 am

Smokers’ Lung Treatment May Fail to Fire Up Nycomed Bidders

Bloomberg

Thu, 04/9/09 - 08:27 am